STOCKHOLDERS' EQUITY (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance			$ 7,262
Net earnings	$ 216	$ 247	416	$ 312
Other comprehensive income (loss)	(252)	63	(265)	(22)
Other comprehensive loss	(38)	$ 337	172	$ 341
Ending balance	$ 7,171		$ 7,171
Dividends declared (in dollar per share)	$ 0.17	$ 0.17	$ 0.34	$ 0.34
Issued common stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 3	$ 3	$ 3	$ 3
Ending balance	3	3	3	3
Capital in excess of par value
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	2,617	2,589	2,637	2,614
Net issuance for executive stock plan	6	3		1
Net issuance of restricted stock	10	10	(5)	(13)
Purchase/sale of noncontrolling interest			1
Ending balance	2,633	2,602	2,633	2,602
Treasury stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,836)	(1,810)	(1,812)	(1,834)
Net issuance for executive stock plan	1		5	3
Net issuance of restricted stock	(1)		11	21
Purchase of treasury stock	(100)		(140)
Ending balance	(1,936)	(1,810)	(1,936)	(1,810)
Retained earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	6,830	6,321	6,671	6,296
Dividends declared	(41)	(41)	(82)	(81)
Net earnings	216	247	416	312
Ending balance	7,005	6,527	7,005	6,527
Accumulated other comprehensive income (loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(564)	(736)	(551)	(651)
Other comprehensive income (loss)	(252)	63	(265)	(22)
Ending balance	(816)	(673)	(816)	(673)
Noncontrolling interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	288	287	314	296
Dividends declared	(4)	(4)	(49)	(37)
Purchase/sale of noncontrolling interest		(33)	(4)	(33)
Acquisition of AKASOL		96		96
Net earnings	15	27	39	56
Other comprehensive loss	(17)		(18)	(5)
Ending balance	$ 282	$ 373	$ 282	$ 373